Last reviewed · How we verify
NCT05375058
Complicated Appendicitis During the COVID-19 Pandemic in Jordan
trial testing Observational Study in COVID-19 in 257 participants. Completed in 28 December 2020.
28 December 2020
Quick facts
| Lead sponsor | Jordan University Hospital |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 257 |
| Start date | 2 March 2019 |
| Primary completion | 28 December 2020 |
| Estimated completion | 28 December 2020 |
| Sites | 1 location across Jordan |
Drugs / interventions tested
- Observational Study — full drug profile →
Conditions studied
- COVID-19 — all drugs for COVID-19 →
- Complicated Appendicitis — all drugs for Complicated Appendicitis →
Sponsor
Jordan University Hospital
Who can join
Eligibility, any sex, with COVID-19 or Complicated Appendicitis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Comparing the incidence of complicated appendicitis between two groups, the pandemic and pre-pandemic groups.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05375058
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Observational Study
Trials testing the same drug.
- NCT07534046 — Impact of Metabolic Disorders on cACLD Outcomes · not yet recruiting
- NCT07353138 — Preoperative Neutrophil-to-Lymphocyte Ratio and Early Postoperative Pain After Septorhinoplasty · not yet recruiting
- NCT07151768 — Prospective Validation of the Novel PVD-B65 Risk Score in Patients With Chronic Lung Disease and Pulmonary Hypertension · recruiting
- NCT06601439 — Utilization of Maternal Healthcare Services and Infant Feeding Practices · active not recruiting
- NCT06702436 — Invasive vs. Conservative Management in Cancer Patients With Non-ST Elevation MI (CAN-NSTEMI)" · completed
Other recruiting trials for COVID-19
Currently open trials in the same condition.
- NCT07183709 — Safety and Immunogenicity Trial of PepGNP-COVID19 Vaccine in Adults · Phase 1 · active not recruiting
- NCT07300839 — A Study to Learn About a COVID-19 Vaccine in Healthy Adults 50 Through 64 Years of Age · Phase 3 · active not recruiting
- NCT07221162 — A Safety and Immunogenicity Trial of Boost-2867 Vaccine, Via Intranasal and Intramuscular Routes · Phase 1 · recruiting
- NCT07215520 — Safety and Tolerability of a Newcastle Disease Virus-Based Mucosal COVID-19 Vaccine in Previously Vaccinated Adults · Phase 2 · recruiting
- NCT07222384 — A Study to Learn About BNT162b2 (LP.8.1)-Adapted Vaccine Against SARS-CoV-2 in Children 5 Through 11 Years of Age That A · Phase 3 · active not recruiting
Other Jordan University Hospital trials
Trials by the same sponsor.
- NCT06827665 — Clinical and Radiographic Evaluation of Allogenic Dentin Grafts for Alveolar Ridge Preservation · Phase 1, PHASE2 · recruiting
- NCT05205707 — Association of Circulating ACE2 Levels With COVID-19 · completed
- NCT04980170 — Clindamycin Versus Amoxicillin With Clavulanic Acid in Prevention of Early Dental Implants Failure · EARLY_PHASE1 · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05375058 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Jordan University Hospital
- Last refreshed: 16 May 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05375058.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing